Mangoceuticals (MGRX) announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the ...

Vice President Kamala Harris wants more drugs to be negotiated by Medicare, but her plan to implement an expansion if elected president remains unclear.

Editas is partnering its CRISPR platform with Genevant’s LNP technology to develop novel gene editing medicines in a deal worth $283m.

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...

The IOF highlights the importance of collaborative efforts in treating osteoporosis, ensuring appropriate care globally.

The American Heart Association and the American Stroke Association issued guidelines Monday that also look at the effects of testosterone and estrogen on the body. Meanwhile, Eli Lilly sues three ...

Mangoceuticals, Inc. (MGRX), a provider of men's health and wellness products, announced on Tuesday that its Board has initiated a ...

Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on ...

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products ...

Mangoceuticals (MGRX) said it strongly refutes claims made in a lawsuit filed by Eli Lilly (LLY) over a compounded version of ...